Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTLHealthcare · Biotechnology
-1.51%$1.96
AH$1.96-0.02%vs close
Mkt Cap$192.34M
Float96.76M
O/S98.13M
Vol
$ Vol
RVOL
Inst Own48.0%
SI6.2%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$137.06M
Total Assets$288.97M
Free Cash Flow-$125.25M
Debt & Equity
Debt 15%
Equity 85%
Total Debt$39.58M
Total Equity$216.2M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ZNTL's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$288.97M
Liabilities$72.76M
Accounts Receivable$1.93M
Accounts Payable$7.21M
Inventory$0
PP&E (Net)$29.04M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $0 | $67.42M | $0 | $0 | $0 | $0 | $0 | $14K |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $67.42M | $0 | $0 | $0 | $0 | $0 | $14K |
| Gross Margin | - | 100.0% | - | - | - | - | - | 100.0% |
| Research and Development | $107.3M | $167.77M | $235.16M | $172.73M | $175.6M | $84.9M | $38.39M | $18.92M |
| Selling, General, and Administrative | $37.72M | $87.11M | $59.4M | $54.55M | $40.94M | $33.89M | $8.46M | $4.88M |
| Other | $7.8M | $3.74M | $4.95M | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $152.81M | $258.62M | $299.51M | $227.29M | $216.54M | $118.79M | $46.84M | $23.8M |
| Operating Income (EBIT) | -$152.81M | -$191.19M | -$299.51M | -$227.29M | -$216.54M | -$118.79M | -$46.84M | -$23.78M |
| Operating Margin | - | -283.6% | - | - | - | - | - | -169878.6% |
| Interest Expense | $0 | $0 | $0 | $2.58M | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $2K | $0 | $0 | $498K | $355K |
| Other Income (Expense) | $16.19M | $25.5M | $6.6M | -$10.29M | $50.15M | $683K | $482K | $355K |
| Income Before Tax (EBT) | -$136.62M | -$165.69M | -$292.91M | -$237.58M | -$166.39M | -$118.1M | -$46.36M | -$23.43M |
| Income Tax Expense | $442K | $177K | -$601K | -$469K | -$297K | $444K | $15K | $4K |
| Net Income | -$137.06M | -$165.84M | -$292.19M | -$236.81M | -$158.72M | -$117.84M | -$45.66M | -$21.07M |
| Net Income Margin | - | -246.0% | - | - | - | - | - | -150478.6% |
| Supplementary Data | ||||||||
| EPS | -1.91 | -2.33 | -4.47 | -4.48 | -3.72 | -2.87 | -1.29 | -1.17 |
| Diluted EPS | -1.91 | -2.33 | -4.47 | -4.48 | -3.72 | -2.87 | -1.29 | -1.17 |
| Weighted Average OS | 71.87M | 71.08M | 65.41M | 52.86M | 42.69M | 41.04M | 35.88M | 18.06M |
| EBITDA | -$144.27M | -$186.17M | -$247.6M | -$233.58M | -$207.2M | -$118.63M | -$46.73M | -$23.73M |
| EBITDA Margin | - | -276.1% | - | - | - | - | - | -169514.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $35.99M | $33.9M | $28.04M | $43.07M | $59.96M | $54.95M | $67.25M | $25.15M |
| Short-Term Investments | $209.9M | $337.18M | $454.88M | $394.3M | $280.17M | $283.55M | $0 | $0 |
| Cash and Short-Term Investments | $245.89M | $371.08M | $482.92M | $437.37M | $340.13M | $338.5M | $67.25M | $25.15M |
| Accounts Receivable | $1.93M | $5M | $0 | $0 | $2.63M | $0 | $140K | $917K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $5.37M | $0 | $13.8M | $14.56M | $0 | $417K | $0 | $0 |
| Total Current Assets | $253.19M | $386.07M | $496.72M | $451.93M | $350.77M | $345.1M | $68.89M | $26.68M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $29.04M | $37.23M | $41.73M | $50.08M | $52.84M | $3.62M | $2.84M | $260K |
| Goodwill | $0 | $0 | $3.74M | $3.74M | $3.74M | $3.74M | $3.74M | $3.74M |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $8.8M | $8.8M | $8.8M |
| Long-Term Investments | $0 | $2.63M | $2.68M | $23.84M | $40.12M | $0 | $243K | -$46K |
| Deferred Tax Assets | $0 | $0 | $10.34M | $14.15M | $17.52M | $0 | $751K | $46K |
| Other Long-Term Assets | $6.74M | $4.42M | $6.82M | $9.72M | $7.04M | $4.3M | $2.97M | $1.52M |
| Total Long-Term Assets | $35.78M | $44.27M | $65.31M | $101.52M | $121.25M | $20.45M | $19.34M | $14.32M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $288.97M | $430.34M | $562.03M | $553.46M | $472.02M | $365.56M | $88.23M | $41M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $7.21M | $7.44M | $14.93M | $11.25M | $11.59M | $8.66M | $4.29M | $3.43M |
| Short-Term Debt | $3.87M | $3.07M | $2.62M | $0 | $1.45M | $0 | $781K | $0 |
| Current Income Tax Payable | $0 | $0 | $281K | $0 | $971K | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $281K | $0 | $0 | $0 | $0 | $223K |
| Other Current Liabilities | $15.51M | $29.42M | -$2.9M | $384K | $20.68M | $410K | $6.85M | $223K |
| Total Current Liabilities | $36.56M | $52.73M | $69.37M | $56.65M | $43.94M | $28.6M | $14.9M | $6.21M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $10.34M | $15M | $19.14M | $0 | $3.21M | $2.46M |
| Other Long-Term Liabilities | $500K | $849K | $1.78M | $2.62M | $0 | $2.48M | $5K | $21K |
| Total Long-Term Liabilities | $36.2M | $40.43M | $55.27M | $62.79M | $63.6M | $3.58M | $4.91M | $2.48M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $72.76M | $93.15M | $124.64M | $119.43M | $107.54M | $32.18M | $19.81M | $8.69M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $141.71M | $59.83M |
| Common Stock | $69K | $71K | $70K | $59K | $45K | $41K | $2.89M | $2.27M |
| Retained Earnings | -$1.19B | -$1.05B | -$888.56M | -$596.37M | -$359.56M | -$200.83M | -$82.99M | -$37.33M |
| Comprehensive Income & Other | $196K | $558K | $2.19M | -$1.35M | -$125K | $36K | $0 | -$56K |
| Other Stockholders' Equity | $1.41B | $1.39B | $1.33B | $1.03B | $723.47M | $509.38M | $141.71M | $59.83M |
| Total Equity | $216.2M | $337.19M | $437.28M | $433.8M | $363.95M | $308.58M | $61.6M | $24.77M |
| Minority Interest | $0 | $0 | $107K | $221K | $528K | $24.8M | $6.82M | $7.54M |
| Total Liabilities and Equity | $288.97M | $430.34M | $561.92M | $553.24M | $471.5M | $340.76M | $81.41M | $33.46M |
| Supplementary Data | ||||||||
| Total Debt | $39.58M | $42.65M | $45.77M | $47.33M | $45.91M | $2M | $2.48M | $0 |
| Net Debt | $3.58M | $8.75M | $17.73M | $4.26M | -$14.04M | -$52.95M | -$64.77M | -$25.15M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$137.06M | -$165.87M | -$292.19M | -$237.11M | -$166.09M | -$118.55M | -$46.38M | -$23.43M |
| Depreciation & Amortization | $739K | $1.29M | $1.39M | $1.43M | $544K | $160K | $111K | $51K |
| Deferred Income Tax | $0 | $0 | -$853K | -$769K | -$2.51M | $17K | $0 | $2.37M |
| Stock-Based Compensation | $20.72M | $67.27M | $54.82M | $46.84M | $35.74M | $23.15M | $617K | $308K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $5M | -$5M | $0 | $0 | $413K | -$277K | $777K | -$254K |
| Inventory | $0 | $0 | $0 | $0 | $0 | -$5.52M | $0 | -$1.86M |
| Accounts Payable | -$17.32M | -$18.02M | $10.92M | $15.53M | $13.96M | $14.31M | $7.12M | $977K |
| Other Working Capital | $3.19M | $6.48M | -$5.05M | -$2.27M | $2.23M | -$667K | -$1.39M | -$40K |
| Total Working Capital Change | -$9.12M | -$16.54M | $5.86M | $13.25M | $16.61M | $7.84M | $6.51M | -$1.18M |
| Other Non-Cash Items | -$526K | -$57.01M | $23.15M | $12.61M | -$38.38M | $556K | $0 | -$2.37M |
| Net Cash from Operating | -$125.25M | -$170.86M | -$207.82M | -$163.75M | -$154.09M | -$86.83M | -$39.14M | -$24.25M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | -$221K | -$583K | -$2.55M | -$6.11M | -$758K | -$352K | -$227K |
| Acquisitions | $0 | $65K | $0 | $112K | -$14.32M | $18.42M | $0 | $0 |
| Purchases of Investments | -$139.49M | -$127.96M | -$549.18M | -$533.16M | -$363.51M | -$400.98M | $0 | $0 |
| Sales of Investments | $270.41M | $304.68M | $505.31M | $421.53M | $365.82M | $116.91M | $0 | $0 |
| Other Investing Activities | $698K | $0 | $0 | -$112K | $0 | -$18.42M | $0 | $0 |
| Net Cash from Investing | $131.62M | $176.56M | -$44.46M | -$114.18M | -$18.11M | -$284.83M | -$352K | -$227K |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | - |
| Common Stock Issuance | -$4.28M | $349K | $237.3M | $261.04M | $179.67M | $327.79M | $0 | $16K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$241K | $0 | $0 | -$1.15M | $18.42M | -$46K | $0 |
| Net Cash from Financing | -$4.28M | $108K | $237.3M | $261.04M | $178.52M | $360.44M | $81.83M | $9.47M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $2.09M | $5.81M | -$14.98M | -$16.89M | $6.31M | -$11.22M | $42.34M | -$15.01M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$125.25M | -$170.86M | -$207.82M | -$163.75M | -$154.09M | -$86.83M | -$39.14M | -$24.25M |
| Capital Expenditure | $0 | -$221K | -$583K | -$2.55M | -$6.11M | -$758K | -$352K | -$227K |
| Free Cash Flow | -$125.25M | -$171.08M | -$208.41M | -$166.3M | -$160.2M | -$87.58M | -$39.49M | -$24.48M |
| Cash at Beginning | $36.53M | $30.72M | $45.7M | $62.58M | $56.27M | $67.49M | $25.15M | $40.16M |
| Cash at End | $38.62M | $36.53M | $30.72M | $45.7M | $62.58M | $56.27M | $67.49M | $25.15M |